Skip to content
Brand AI

Carna Biosciences

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2022

    Brickell Biotech acquires exclusive rights to Carna Biosciences’ autoimmune drug portfolio

    Brickell Biotech announced that it acquired exclusive rights to develop and commercialize a portfolio of autoimmune drugs created by Carna Biosciences.

    Source